Best Practice & Research Clinical Haematology
Volume 21, Issue 2 , Pages 165-176, June 2008

Prophylaxis of acute GVHD: manipulate the graft or the environment?

  • A. John Barrett, MD, FRCP, FRCPath (UK) (Chief, Stem Cell Allotransplantation Section)
  • Katarina Le Blanc, MD, PhD (Professor of Clinical Stem Cell Research, Hematology Center)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +46 8 585 89463; Fax: +46 8 746 6699.

Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA

Division of Clinical Immunology and Transfusional Medicine, F79, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86 Stockholm, Sweden

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(08)00005-4

doi:10.1016/j.beha.2008.02.004

Best Practice & Research Clinical Haematology
Volume 21, Issue 2 , Pages 165-176, June 2008